While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most important difference is that medical devices do not achieve their principal action by pharmacological means. This means they have fewer opportunities to interact with the human body as compared to the possible systemic effects associated with pharmaceuticals.